Cargando…

Recovery capital among people receiving treatment for opioid use disorder with buprenorphine

BACKGROUND: Recovery is a multidimensional process that includes health, quality of life, and citizenship. Recovery capital is a strengths-based concept representing the sum of an individual’s resources that support recovery. This study (1) describes recovery capital, (2) examines the relationship b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Parlier-Ahmad, Anna Beth, Terplan, Mishka, Svikis, Dace S., Ellis, Laura, Martin, Caitlin E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8513247/ https://www.ncbi.nlm.nih.gov/pubmed/34645477 http://dx.doi.org/10.1186/s12954-021-00553-w

Ejemplares similares

Project BETTER: A Family-Centered, Technology-Delivered Intervention for Pregnant People with Opioid Use Disorder
por: Parlier-Ahmad, Anna Beth, et al.
Publicado: (2023)

What Recovery Means to Postpartum Women in Treatment for Opioid Use Disorder
por: Shadowen, Caroline, et al.
Publicado: (2022)

Project BETTER: Preliminary Feasibility and Acceptability of a Technology-Delivered Educational Program for Pregnant and Postpartum People with Opioid Use Disorder
por: Martin, Sarah, et al.
Publicado: (2022)

Social determinants of health and emergency department utilization among adults receiving buprenorphine for opioid use disorder
por: Radic, Maja, et al.
Publicado: (2022)

Patient reported preferences for sleep interventions among women receiving buprenorphine for opioid use disorder
por: Eglovitch, Michelle, et al.
Publicado: (2023)

Erratum to ‘Social determinants of health and emergency department utilization among adults receiving buprenorphine for opioid use disorder’ [Drug and Alcohol Dependence Reports 3 (2022) 100062]
por: Radic, Maja, et al.
Publicado: (2022)

Treatment Outcomes Among Black Adults Receiving Medication for Opioid Use Disorder
por: Parlier-Ahmad, Anna Beth, et al.
Publicado: (2021)

Development and clinical feasibility study of a brief version of an addiction‐focused phenotyping battery in females receiving buprenorphine for opioid use disorder
por: Parlier‐Ahmad, Anna Beth, et al.
Publicado: (2023)

Prevalence and Social Acceptability of Cannabis, Tobacco, and Alcohol Use in Adult Women
por: Coughenour, Patricia, et al.
Publicado: (2021)

Chronic Pelvic Pain and Sexual Dysfunction Among Females and Males Receiving Treatment for Opioid Use Disorder
por: Reichmann, Geetika, et al.
Publicado: (2022)

Interest in Co-located Reproductive and Sexual Health Services Among Women and Men Receiving Medication for Opioid Use Disorder in an Outpatient Treatment Clinic
por: Stoltman, Jonathan J. K., et al.
Publicado: (2022)

Principles of care for pregnant and parenting people with substance use disorder: the obstetrician gynecologist perspective
por: Barber, Cecily May, et al.
Publicado: (2023)

Psychiatric comorbidities and their treatment predict buprenorphine continuation among postpartum people with opioid use disorder
por: Shadowen, Hannah, et al.
Publicado: (2022)

Availability of Medications for the Treatment of Opioid Use Disorder Among Pregnant and Postpartum Individuals in US Jails
por: Sufrin, Carolyn, et al.
Publicado: (2022)

Medication treatment for opioid use disorder in expectant mothers (MOMs): Design considerations for a pragmatic randomized trial comparing extended-release and daily buprenorphine formulations
por: Winhusen, Theresa, et al.
Publicado: (2020)

Buprenorphine‐naloxone, buprenorphine, and methadone throughout pregnancy in maternal opioid use disorder
por: Kanervo, Minna M., et al.
Publicado: (2022)

Patients Maintained on Buprenorphine for Opioid Use Disorder Should Continue Buprenorphine Through the Perioperative Period
por: Lembke, Anna, et al.
Publicado: (2019)

Managing opioid withdrawal precipitated by buprenorphine with buprenorphine
por: Oakley, Bridget, et al.
Publicado: (2021)

The Pharmacology of Buprenorphine Microinduction for Opioid Use Disorder
por: De Aquino, Joao P., et al.
Publicado: (2021)

Sex Specific Sleep Parameters Among People With Substance Use Disorder
por: Martin, Caitlin E., et al.
Publicado: (2022)

Characterizing opioid use disorder patients who have received medication trials with both buprenorphine and methadone
por: Wilder, Christine M, et al.
Publicado: (2015)

Personalized Care in Opioid Use Disorder maintained on Buprenorphine
por: Elarabi, H., et al.
Publicado: (2022)

Inpatient Buprenorphine Induction for Opioid Use Disorder in Pregnancy
por: Tavakoli, Amin, et al.
Publicado: (2023)

Analysis of Stimulant Prescriptions and Drug-Related Poisoning Risk Among Persons Receiving Buprenorphine Treatment for Opioid Use Disorder
por: Mintz, Carrie M., et al.
Publicado: (2022)

Perceptions of extended‐release buprenorphine injections for opioid use disorder among people who regularly use opioids in Australia
por: Larance, Briony, et al.
Publicado: (2020)

Obstetrician-Gynecologists’ practice patterns related to opioid use during pregnancy and postpartum - United States, 2017
por: Ko, Jean Y., et al.
Publicado: (2019)

Comparison of Buprenorphine and Buprenorphine/naloxone in Detoxification of Opioid-dependent Men
por: Ziaaddini, Hassan, et al.
Publicado: (2018)

Contraceptive utilization among new exotic dancers: a cross-sectional study
por: Terplan, Mishka, et al.
Publicado: (2018)

Co-occurring psychiatric disorders and disparities in buprenorphine utilization in opioid use disorder: An analysis of insurance claims
por: Xu, Kevin Y, et al.
Publicado: (2023)

Perioperative opioid requirements of patients receiving sublingual buprenorphine-naloxone: a case series
por: Martin, Yvette N., et al.
Publicado: (2019)

A review of the pharmacogenomics of buprenorphine for the treatment of opioid use disorder
por: Seguí, Hemanuel Arroyo, et al.
Publicado: (2020)

Hospitalist perspectives on buprenorphine treatment for inpatients with opioid use disorder
por: Reed, Megan K, et al.
Publicado: (2022)

Pharmacy Availability of Buprenorphine for Opioid Use Disorder Treatment in the US
por: Weiner, Scott G., et al.
Publicado: (2023)

Recovery Capital Gains May Precede Craving Reduction in Opioid Use Disorder
por: Bormann, Nicholas L, et al.
Publicado: (2023)

Addressing stigma within the dissemination of research products to improve quality of care for pregnant and parenting people affected by substance use disorder
por: Lipsett, Megan, et al.
Publicado: (2023)

Prescribing of Opioid Analgesics and Buprenorphine for Opioid Use Disorder During the COVID-19 Pandemic
por: Currie, Janet M., et al.
Publicado: (2021)

Willingness to receive intravenous buprenorphine treatment in opioid-dependent people refractory to oral opioid maintenance treatment: results from a community-based survey in France
por: Roux, Perrine, et al.
Publicado: (2017)

Advances in the delivery of buprenorphine for opioid dependence
por: Rosenthal, Richard N, et al.
Publicado: (2017)

Role of Buprenorphine in an Adolescent with Opioid Abuse
por: Weesner, Elizabeth, et al.
Publicado: (2022)

Against professional advice: treatment attrition among pregnant methamphetamine users
por: Lindsay, Brianna, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_kk4mo1720bvrkdqijksfj857vq